Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

Ms Pegs1, no earthly idea when or if!

Biotech giant helps itself without swallowing Galapagos whole
A ten-year collaboration gives biotech giant Gilead first rights to all of Galapagos’s pipeline.

Melanie Senior

The interesting part of Gilead’s expansive R&D collaboration with Galapagos is what it claims it is not: an acquisition. Instead, Gilead—helmed by Roche veteran Daniel O’Day—not only has paid Galapagos $3.95

https://www.nature.com/articles/d41587-019-00024-5?proof=t+target%3D